Myriad Genetics buy The Goldman Sachs Group, Inc.
Start price
29.01.24
/
50%
€21.00
Target price
29.01.25
€28.68
Performance (%)
11.43%
Price
27.09.24
€23.40
Summary
This prediction is currently active. The prediction currently has a performance of 11.43%. This prediction currently runs until 29.01.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Myriad Genetics | -5.645% | -5.645% |
iShares Core DAX® | 3.523% | 3.763% |
iShares Nasdaq 100 | 1.026% | 2.380% |
iShares Nikkei 225® | -0.063% | 0.000% |
iShares S&P 500 | 0.557% | 2.222% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $28.00 to $31.00. They now have a "buy" rating on the stock.
Ratings data for MYGN provided by MarketBeat